Digital Health

Wrote and negotiated a Telemedicine and Pharmacy Fulfillment Agreement for a women’s health telemedicine direct-to-consumer startup.

Provided privacy analysis for a national retailer establishing a direct-to-consumer telemedicine platform.

Assisted a medical supplier with patent applications directed to monitoring and improving patient compliance with dialysis treatments.

Advised a US health care software provider in contract negotiations with a German reseller in the hospital sector. 

Assisted a medical device company in filing a post-grant review against a medical technology company focused on heart care for a patent related to determining fractional flow values in a patient’s coronary arteries.

Advised a leader in medical device connectivity in the context of distribution of medical SaaS software in Germany. 

Advised a China-based health care product developer in relation to the introduction of a digital blood glucose-tracking device and app on the German market in compliance with German and EU privacy laws.

Developed/prepared compliance protocol for a medical laboratory to determine validity of telemedicine orders from referring providers.

Advised a Paris, France-based evergreen investment firm operating worldwide, as lender in connection with a US$1.6 million bridge loan financing to a California-based digital health company.

Assisted a digital health coach with patent applications directed to a mobile application to help patients manage their diabetes.

Assisted in reviewing health care regulatory issues for patient engagement software.

Advised a health care app in all contractual and privacy matters related to a digital patient platform where patients can upload health data, share with professionals, and purchase additional health services and products.

Assisted a molecular diagnostics company in regulatory diligence for an artificial intelligence-driven patient engagement platform for cancer therapy.

Represented a chief executive officer of a health care corporation in connection with a federal criminal health care fraud investigation into telemedicine-related arrangements.

Assisted an innovator of software-enabled pharmacy automation technologies with patent applications directed to digital pharmacy automation management and remote verification.

Advised an online health care provider on potential cartel-related issues and merger-control issues relating to the potential sale of its e-scripts business.

Assisted an intellectual property law firm with handling patent applications for predicting thyrotoxivosis using a wearable device and computer program.

Represented a multistate hospital system in the acquisition of a specialist telehealth platform valued in excess of US$30 million.

Advised a California-based health website, one of the fastest-growing publishers of digital health media, in the sale of the assets which comprised its e-commerce division.

Researched and wrote a health care regulatory analysis of provision of direct-to-consumer telemedicine and pharmacy fulfillment services nationally for an existing drug distribution company with licensed pharmacies in multiple states.

Defended a multispecialty medical care provider in a commercial insurance audit of telemedicine services in its obesity practice.

Advised a digital health system that provides innovative, data driven solutions to improve quality, efficiency, and outcomes in neurological and musculoskeletal care regarding innovative, value-based arrangements to provide specialty surgical care. 

Advised a nonprofit organization conducting oncologic clinical research in the preparation and negotiation of a data-sharing agreement with the University of Pennsylvania regarding evaluation of whether tumor genetic, microenvironment, and blood translational parameters from patients could predict clinical outcomes, namely, overall response rate, progression-free survival, overall survival, and presence of grade 3 and higher immune-related adverse events.

Advised a Sydney, Australia-based global trading company on its sale to a California-headquartered global medical technology company that develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation solutions, home monitoring devices, ventilation solutions, and consumer products.

Advised a US-based health care service company regarding privacy compliance issues and negotiations with EU-based customers.

Defended a physician in a Medicaid investigation of substance abuse services delivered via telemedicine. 

Counseled a developer of health care technology regarding multiple patent applications for a blood sampling and glucose-sensing device.

Supplied key regulatory advice to a technology bridge connecting patients to therapies with speed and efficiency in relation to structuring telehealth services.

Provided legal analysis and guidance to a health care artificial intelligence company in relation to the ONC’s Information Blocking and HIT Certification Rules.

Provided detailed advice and guidance to a not-for-profit health system regarding ONC’s Information Blocking Rule and HIT Certification requirements.

Assisted a leading US-based provider of comprehensive sleep apnea care on a complex corporate and health care regulatory review of its business model and management services involving management of telehealth, physician practices, dental practices, independent diagnostic testing facilities, and durable medical supply companies regarding sleep and respiratory care products.

Advised a US-based independent specialized provider of non-invasive ventilation in the home on the formation of a subsidiary to stand up new business to provide remote patient monitoring, telehealth, social work, and respiratory services. 

Represented a telehealth device manufacturer in its development of a corporate structure to facilitate its business objectives.

Advised a not-for-profit health care organization regarding compliance with the 21st Century Cures Act, which instituted an information-blocking rule whereby certain entities may not knowingly take actions that interfere with access, exchange, or use of electronic health information.

Advised a leading US-based provider of customised health support to health plans and health care delivery systems on the formation and build-out of its business model, which is the provision of remote patient monitoring services and equipment to durable medical equipment suppliers and physician offices across the country.